| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $478,136,100 ) (Continued on the next page) |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R00HD114849 | Adaptation and pilot testing of a couples-based intervention to prevent perinatal depression in rural India | 001 | 3 | NIH | 7/1/2026 | $44,794 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R00HD114849 | Adaptation and pilot testing of a couples-based intervention to prevent perinatal depression in rural India | 000 | 3 | NIH | 6/22/2026 | $204,206 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01HL182930 | Airway epithelial cell reprogramming mechanisms leading to chronic lung allograft dysfunction | 000 | 1 | NIH | 5/1/2026 | $731,287 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K23DK147767 | Assessment of Body Composition in Adolescents with T2D on Glucagon-like-peptide receptor agonists (GLP-1RAs) (ABC Study) | 000 | 1 | NIH | 5/4/2026 | $203,244 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | F30MH144874 | Neural mechanisms of memory consolidation in the hippocampus and medial prefrontal cortex | 000 | 1 | NIH | 4/29/2026 | $50,078 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | F31DK145093 | Characterizing RasGRP1 as a critical regulator of the chemosensory tuft cell lineage in the intestine | 001 | 1 | NIH | 6/17/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | F31DK145093 | Characterizing RasGRP1 as a critical regulator of the chemosensory tuft cell lineage in the intestine | 000 | 1 | NIH | 6/17/2026 | $43,101 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K08MH144328 | Circuit Mechanisms of Social Attachment in the Prairie Vole Medial Amygdala | 000 | 1 | NIH | 5/14/2026 | $209,520 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R24ES036003 | Expanding a Pregnancy Cohort from the San Francisco Bay Area to Improve Data Access and Individual Results Return on Environmental Exposures to Participant Communities | 000 | 3 | NIH | 3/26/2026 | $387,927 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K99GM160780 | Illuminating jumbo phage infection mechanisms: from complex prokaryotic cell biology to novel therapeutics | 000 | 1 | NIH | 5/13/2026 | $123,147 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K99NS142566 | Impact of Pathological Tau on Circuit Function in Phenotypic Mouse Models of Progressive Supranuclear Palsy | 000 | 1 | NIH | 1/22/2026 | $136,620 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01DK140948 | Contributions of Volume Overload Level and Ultrafiltration to Morbidity in ESKD | 001 | 2 | NIH | 7/2/2026 | $722,305 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R21CA303378 | Multi-Modality Modeling of Glioblastoma Progression: Integrating DTI and Prognostic Biomarkers for Personalized Radiation Therapy Targeting | 000 | 1 | NIH | 5/1/2026 | $414,402 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01AG092420 | CRISPR for tauopathy | 000 | 1 | NIH | 1/30/2026 | $680,792 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R01AG092810 | The Impact of Changes in Primary Care Clinicians' Work Effort on the Health of Older Adults | 000 | 1 | NIH | 3/25/2026 | $680,086 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K23MH138756 | Understanding and Altering Prenatal Immune Function and Parenting to Improve Child Mental Health: Investigating Intergenerational Stress Transmission Mechanisms | 000 | 1 | NIH | 3/19/2026 | $200,376 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R33AG087921 | Exploring the differential spreading of distinct pathological conformers of AD/LBD-related proteins by combining mathematical modeling and functional study | 000 | 3 | NIH | 7/3/2026 | $793,233 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01NS128217 | Gene therapy for disorders of the extracellular matrix | 000 | 2 | NIH | 4/24/2026 | $821,991 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01DK147971 | ASB4 in feeding regulation | 000 | 1 | NIH | 5/8/2026 | $607,612 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K08CA312446 | Targeting TOX-Imposed Epigenetic and Transcriptional Circuits to Restore T Cell Function in Cancer | 000 | 1 | NIH | 7/3/2026 | $237,546 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | K01AG094343 | Strengthening Clinical Support for Providers Working with Women Living with HIV to Manage Menopause | 001 | 2 | NIH | 5/19/2026 | $131,598 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01AG094900 | Policing, Housing, and Health Outcomes in Older Homeless Adults | 000 | 2 | NIH | 4/20/2026 | $676,516 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01MH139197 | Molecular and functional dissection of prefrontal-hippocampal long-range inhibition | 000 | 1 | NIH | 3/10/2026 | $800,384 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K23AG090757 | Deciphering the molecular landscape of frontotemporal lobar degeneration: A network-based proteomic approach | 000 | 2 | NIH | 5/8/2026 | $200,182 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01HL138626 | The Role of Early-Life Viral Respiratory Illness in Development of Childhood Asthma Endotypes: the PRIMERO II study | 000 | 6 | NIH | 5/8/2026 | $1,319,983 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01AI197222 | AMR Monitoring to Improve Child’s Health and Mortality | 000 | 1 | NIH | 6/29/2026 | $597,421 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01AI200744 | Modeling dynamic CD8+ T cell-virus interactions in post-treatment control of HIV | 000 | 1 | NIH | 5/11/2026 | $874,531 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | R56AG046400 | Linking metabolism, neural function, and aging | 001 | 11 | NIH | 5/29/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R56AG046400 | Linking metabolism, neural function, and aging | 000 | 11 | NIH | 12/29/2025 | $537,590 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R03MH139969 | Exposure to violence and food and mental health security in the occupied Palestinian territories | 000 | 1 | NIH | 5/6/2026 | $164,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01AI189532 | Biophysical constraints on antibody affinity maturation to SARS-CoV-2 | 000 | 1 | NIH | 2/19/2026 | $815,762 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 005 | 1 | NIH | 5/22/2026 | $16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 004 | 1 | NIH | 5/21/2026 | $16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K99ES038229 | Analyzing the Distribution, Effectiveness, and Implementation of Wildfire Smoke Exposure Reduction Strategies on Respiratory Health | 000 | 1 | NIH | 4/16/2026 | $117,747 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 003 | 1 | NIH | 5/21/2026 | $16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | F31AI200462 | Elucidating the biophysical basis of repeatability in the evolution of drug resistance | 001 | 1 | NIH | 5/11/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K99AG097973 | Mapping cerebellar influence in FTD: unraveling the role of the cerebellum in social cognition and clinical trajectory | 000 | 1 | NIH | 2/27/2026 | $119,785 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 009 | 1 | NIH | 6/10/2026 | -$16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 002 | 1 | NIH | 5/21/2026 | $16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | F31AI200462 | Elucidating the biophysical basis of repeatability in the evolution of drug resistance | 000 | 1 | NIH | 5/11/2026 | $44,000 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 008 | 1 | NIH | 6/10/2026 | -$16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103-4249 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 001 | 1 | NIH | 5/13/2026 | $0 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 007 | 1 | NIH | 6/10/2026 | -$16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 000 | 1 | NIH | 5/11/2026 | $492,815 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | UG1EY036344 | Systemic and Topical Antiviral Control of Cytomegalovirus Anterior uveitis: TreatmentOutcomes (STACCATO) | 006 | 1 | NIH | 6/10/2026 | -$16,460 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01AI197969 | Strategies to Predict Success on Long-Acting Therapy in Real-World Settings for HIV (SPLASH) | 000 | 1 | NIH | 5/6/2026 | $772,342 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | R01CA301509 | Functional Avoidance Liver Stereotactic Body Radiation Therapy Guided by MR Multitasking-driven Abdominal Integrated Imaging (MT-AI2) | 000 | 1 | NIH | 3/12/2026 | $700,838 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K08CA300872 | Trauma-Informed Smoking Cessation for Women | 000 | 1 | NIH | 7/2/2026 | $306,304 |
| | 2026 | 2026 | REGENTS OF THE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, THE | 1855 FOLSOM ST STE 425 | SAN FRANCISCO | CA | 94103 | SAN FRANCISCO | USA | K23DK141906 | Use of the electronic health record to target a patient navigation intervention preventing loss to follow up in the treatment of urinary stone disease | 000 | 2 | NIH | 7/1/2026 | $178,729 |
|
